Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 94

Results For "program"

1775 News Found

Ichnos Sciences inks agreement with Astria Therapeutics for OX40 antagonist monoclonal antibody portfolio
News | October 13, 2023

Ichnos Sciences inks agreement with Astria Therapeutics for OX40 antagonist monoclonal antibody portfolio

Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications


IMI 5.0 campaign with special focus on improvement of Measles and Rubella vaccination coverage
Policy | October 13, 2023

IMI 5.0 campaign with special focus on improvement of Measles and Rubella vaccination coverage

Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country


Mandaviya inaugurates new facilities at NIMHANS and launches new logo of Tele-MANAS
Healthcare | October 11, 2023

Mandaviya inaugurates new facilities at NIMHANS and launches new logo of Tele-MANAS

Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells


Ayurveda benefits animal, plant and human life, says Sonowal
News | October 11, 2023

Ayurveda benefits animal, plant and human life, says Sonowal

Ayush Minister launched month long ayurveda celebration drive of Ministry of Ayush


Astellas, BioLabs and Mitsui Fudosan collaborate to enhance life science ecosystems in Tsukuba and Kashiwa-no-ha, Japan
News | October 11, 2023

Astellas, BioLabs and Mitsui Fudosan collaborate to enhance life science ecosystems in Tsukuba and Kashiwa-no-ha, Japan

Astellas stands on the forefront of healthcare change to turn innovative science into value for patients


Veramed acquires Clinical Trial Data Services
News | October 09, 2023

Veramed acquires Clinical Trial Data Services

Clinical Trial Data Services supports small to midsize sponsor companies helping them to take the next step towards market approval for their drug or device product.


Strides receives USFDA approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate tablets
Drug Approval | October 05, 2023

Strides receives USFDA approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate tablets

The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products


Doceree raises US$ 35 million in Series B Funding
News | September 29, 2023

Doceree raises US$ 35 million in Series B Funding

Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe


Mandaviya reviews preparedness to prevent rising dengue cases
Healthcare | September 28, 2023

Mandaviya reviews preparedness to prevent rising dengue cases

Minister was briefed on the nationwide dengue situation